Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates

spike

FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo

(Reuters) – Amgen Inc (AMGN.O) on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.

Otezla, which Amgen acquired last year from Celgene Corp as part of Celgene’s buyout by Bristol Myers Squibb Co (BMY.N), is a pill that helps reduce overactive inflammation. Other similar medicines are also being tested to see if they can help COVID-19 patients.

Amgen, which maintained its full-year earnings forecast, also said it is working with partner Adaptive Biotechnologies Corp (ADPT.O) to identify antibodies targeting the novel coronavirus that may be developed into a drug to potentially prevent or treat COVID-19.

Amgen said strong first-quarter sales of Otezla, along with higher volume sales of drugs like cholesterol treatment Repatha, contributed to an 11% increase in revenue for the period.

The company last year launched a lower-priced Repatha option aimed at reducing out-of-pocket costs for Medicare patients.

The biotechnology company reported an adjusted profit of $4.17 per share, up 17% from a year earlier and well above analysts’ average expectations of $3.76, according to Refinitiv IBES.

Amgen said the results were driven by revenue of $6.16 billion and fewer shares outstanding. That topped Wall Street estimates for revenue of just under $6 billion.

Net profit fell 3% to $3.07 per share due to higher operating costs that were partially offset by the lower share count.

For 2020, the Thousand Oaks, California-based company said it still expects adjusted earnings of $14.85 to $15.60 per share on revenue of $25 billion to $25.6 billion.

Reporting By Deena Beasley; Editing by Bill Berkrot

Source Article

Next Post

What it says about Hollywood

Temporarily closed signs hang on doors at an AMC Entertainment Holdings Inc. movie theater in the Georgetown neighborhood of Washington, D.C. Bloomberg Tensions are running high in the film industry. Studios and exhibitors have been faced with difficult decisions in the wake of the coronavirus pandemic, as both are grappling […]